BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2871646)

  • 1. Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding protein.
    Tolkoff-Rubin NE; Cosimi AB; Delmonico FL; Russell PS; Thompson RE; Piper DJ; Hansen WP; Bander NH; Finstad CL; Cordon-Cardo C
    Transplantation; 1986 May; 41(5):593-7. PubMed ID: 2871646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding protein.
    Tolkoff-Rubin NE; Thompson RE; Piper DJ; Hansen WP; Bander NH; Cordon-Cardo C; Finstad CJ; Klotz LH; Old LJ; Rubin RH
    Nephrol Dial Transplant; 1987; 2(3):143-8. PubMed ID: 2888057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminase binding protein, a new diagnostic marker for kidney disease.
    Thompson RE; Piper DJ; Galberg C; Chan TH; Tolkoff-Rubin NE; Rubin RH
    Clin Chem; 1985 May; 31(5):679-83. PubMed ID: 2859130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new diagnostic immunoassay for proximal tubule injury.
    Thompson RE; Piper DJ; Kidd KA
    Toxicol Pathol; 1986; 14(2):232-7. PubMed ID: 2876488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive idiotype--anti-idiotype immunoassay for adenosine deaminase binding protein in urine.
    Thompson RE; Hewitt CR; Piper DJ; Hansen WP; Rubin RH; Tolkoff-Rubin NE; Barrett MC; Nelles MJ
    Clin Chem; 1985 Nov; 31(11):1833-7. PubMed ID: 2865018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive idiotype-anti-idiotype enzyme immunoassay for adenosine deaminase binding protein.
    Nelles MJ
    Methods Enzymol; 1989; 178():171-9. PubMed ID: 2574818
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary adenosine deaminase binding protein as a predictor of renal transplant rejection in children.
    Iglesias JH; Richard GA
    Transplant Proc; 1994 Feb; 26(1):75-6. PubMed ID: 7906446
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased levels of urinary adenosine deaminase binding protein in children treated with cisplatin or methotrexate.
    Goren MP; Wright RK; Horowitz ME
    Clin Chim Acta; 1986 Oct; 160(2):157-61. PubMed ID: 2877760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay for serum renal tubular antigen in kidney transplant patients.
    Shen SY; Weir MR; Litkowski L; Anthony R; Welik R; Kosenko A; Light PD; Dagher FJ; Sadler JH
    Transplantation; 1985 Dec; 40(6):642-7. PubMed ID: 3907036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
    Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
    Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies.
    Verani RR; Flechner SM; Van Buren CT; Kahan BD
    Am J Kidney Dis; 1984 Sep; 4(2):185-91. PubMed ID: 6383031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.
    Yoshimura N; Oka T; Kahan BD
    Transplantation; 1991 Jan; 51(1):172-6. PubMed ID: 1987687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
    Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
    Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding protein.
    Goren MP; Wright RK; Horowitz ME; Pratt CB
    Am J Clin Pathol; 1986 Dec; 86(6):780-3. PubMed ID: 2878604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of increased urinary excretion of adenosine-deaminase-binding protein by patients with chronic renal tubular malfunction.
    Flynn FV; Lapsley M; Sansom PA; Norden AG
    Clin Chim Acta; 1991 Aug; 200(2-3):183-9. PubMed ID: 1723356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of fine-needle intrarenal manometry in the management of renal transplant patients receiving cyclosporine.
    Salaman JR; Griffin PJ
    Transplantation; 1985 May; 39(5):523-6. PubMed ID: 3887693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of an adenosine deaminase-binding protein in human kidney.
    Schrader WP; Pollara B
    J Lab Clin Med; 1978 Oct; 92(4):656-62. PubMed ID: 361913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
    Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of kidney transplant rejection and ciclosporin nephrotoxicity by urine cytology].
    Kyo M; Mihatsch MJ
    Hinyokika Kiyo; 1991 Oct; 37(10):1153-8. PubMed ID: 1721768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose cyclosporine for cadaveric renal transplantation.
    Vanderwerf BA; Serota AI
    Transplantation; 1988 Feb; 45(2):320-3. PubMed ID: 3278422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.